# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001437749-23-022773
Filing Date
2023-08-09
Accepted
2023-08-09 16:02:01
Documents
36
Period of Report
2023-08-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | dffn20230808_8k.htm iXBRL | 8-K | 45222
2 | EXHIBIT 99.1 | ex_557527.htm | EX-99.1 | 232793
3 | EXHIBIT 99.2 | ex_557528.htm | EX-99.2 | 436418
4 | EXHIBIT 99.3 | ex_556936.htm | EX-99.3 | 13287
9 |  | invpres_page01.jpg | GRAPHIC | 84395
10 |  | invpres_page02.jpg | GRAPHIC | 241288
11 |  | invpres_page03.jpg | GRAPHIC | 275484
12 |  | invpres_page04.jpg | GRAPHIC | 127113
13 |  | invpres_page05.jpg | GRAPHIC | 152751
14 |  | invpres_page06.jpg | GRAPHIC | 101670
15 |  | invpres_page07.jpg | GRAPHIC | 132926
16 |  | invpres_page08.jpg | GRAPHIC | 144913
17 |  | invpres_page09.jpg | GRAPHIC | 148171
18 |  | invpres_page10.jpg | GRAPHIC | 176444
19 |  | invpres_page11.jpg | GRAPHIC | 137334
20 |  | invpres_page12.jpg | GRAPHIC | 131405
21 |  | invpres_page13.jpg | GRAPHIC | 152050
22 |  | invpres_page14.jpg | GRAPHIC | 117087
23 |  | invpres_page15.jpg | GRAPHIC | 102986
24 |  | invpres_page16.jpg | GRAPHIC | 148261
25 |  | invpres_page17.jpg | GRAPHIC | 108351
26 |  | invpres_page18.jpg | GRAPHIC | 101912
27 |  | invpres_page19.jpg | GRAPHIC | 68945
28 |  | invpres_page20.jpg | GRAPHIC | 82918
| Complete submission text file | 0001437749-23-022773.txt |  | 4697667

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | dffn-20230808.xsd | EX-101.SCH | 3408
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dffn-20230808_def.xml | EX-101.DEF | 11423
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dffn-20230808_lab.xml | EX-101.LAB | 15309
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dffn-20230808_pre.xml | EX-101.PRE | 11583
30 | EXTRACTED XBRL INSTANCE DOCUMENT | dffn20230808_8k_htm.xml | XML | 2575

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 231154990
SIC: 2834 Pharmaceutical Preparations